Literature DB >> 23979522

Overexpression of SNORD114-3 marks acute promyelocytic leukemia.

T Liuksiala1, K J Teittinen2, K Granberg1, M Heinäniemi3, M Annala1, M Mäki2, M Nykter4, O Lohi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23979522     DOI： 10.1038/leu.2013.250

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  "Snorkeling" for missing players in cancer.

Authors:  Riccardo Taulli; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2012-07-02       Impact factor: 14.808

2.  Induction of hepatocellular carcinoma by in vivo gene targeting.

Authors:  Pei-Rong Wang; Mei Xu; Sara Toffanin; Yi Li; Josep M Llovet; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

3.  MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.

Authors:  Xi Liu; Lorenzo F Sempere; Haoxu Ouyang; Vincent A Memoli; Angeline S Andrew; Yue Luo; Eugene Demidenko; Murray Korc; Wei Shi; Meir Preis; Konstantin H Dragnev; Hua Li; James Direnzo; Mads Bak; Sarah J Freemantle; Sakari Kauppinen; Ethan Dmitrovsky
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

4.  Specific small nucleolar RNA expression profiles in acute leukemia.

Authors:  W Valleron; E Laprevotte; E-F Gautier; C Quelen; C Demur; E Delabesse; X Agirre; F Prósper; T Kiss; P Brousset
Journal:  Leukemia       Date:  2012-04-23       Impact factor: 11.528

5.  Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.

Authors:  Liang Chu; Mack Y Su; Leonard B Maggi; Lan Lu; Chelsea Mullins; Seth Crosby; Gaofeng Huang; Wee Joo Chng; Ravi Vij; Michael H Tomasson
Journal:  J Clin Invest       Date:  2012-07-02       Impact factor: 14.808

6.  Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells.

Authors:  Lei Liu; Guan-Zheng Luo; Wei Yang; Xiaoyang Zhao; Qinyuan Zheng; Zhuo Lv; Wei Li; Hua-Jun Wu; Liu Wang; Xiu-Jie Wang; Qi Zhou
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

7.  Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia.

Authors:  Amanda Dixon-McIver; Phil East; Charles A Mein; Jean-Baptiste Cazier; Gael Molloy; Tracy Chaplin; T Andrew Lister; Bryan D Young; Silvana Debernardi
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

8.  The increased expression of 14q32 small nucleolar RNA transcripts in promyelocytic leukemia cells is not dependent on PML-RARA fusion gene.

Authors:  Y Cohen; K Hertzog; O Reish; M Mashevich; O Garach-Jehoshua; A Bar-Chaim; L Trakhtenbrot; A Kornberg
Journal:  Blood Cancer J       Date:  2012-10-12       Impact factor: 11.037

Review 9.  Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease.

Authors:  Michael Girardot; Jérôme Cavaillé; Robert Feil
Journal:  Epigenetics       Date:  2012-11-15       Impact factor: 4.528

10.  Gene-pair expression signatures reveal lineage control.

Authors:  Merja Heinäniemi; Matti Nykter; Roger Kramer; Anke Wienecke-Baldacchino; Lasse Sinkkonen; Joseph Xu Zhou; Richard Kreisberg; Stuart A Kauffman; Sui Huang; Ilya Shmulevich
Journal:  Nat Methods       Date:  2013-04-21       Impact factor: 28.547
View more
  12 in total

1.  Expression profiling of snoRNAs in normal hematopoiesis and AML.

Authors:  Wayne A Warner; David H Spencer; Maria Trissal; Brian S White; Nichole Helton; Timothy J Ley; Daniel C Link
Journal:  Blood Adv       Date:  2018-01-23

Review 2.  Dysregulation of Small Nucleolar RNAs in B-Cell Malignancies.

Authors:  Martijn W C Verbeek; Stefan J Erkeland; Vincent H J van der Velden
Journal:  Biomedicines       Date:  2022-05-24

3.  Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer.

Authors:  Sonia Molina-Pinelo; Ana Salinas; Nicolás Moreno-Mata; Irene Ferrer; Rocío Suarez; Eduardo Andrés-León; Manuel Rodríguez-Paredes; Julian Gutekunst; Eloisa Jantus-Lewintre; Carlos Camps; Amancio Carnero; Luis Paz-Ares
Journal:  Oncotarget       Date:  2016-07-15

4.  A Comprehensive NGS Data Analysis of Differentially Regulated miRNAs, piRNAs, lncRNAs and sn/snoRNAs in Triple Negative Breast Cancer.

Authors:  Srinivas V Koduru; Amit K Tiwari; Ashley Leberfinger; Sprague W Hazard; Yuka Imamura Kawasawa; Milind Mahajan; Dino J Ravnic
Journal:  J Cancer       Date:  2017-02-11       Impact factor: 4.207

5.  SNORD76, a box C/D snoRNA, acts as a tumor suppressor in glioblastoma.

Authors:  Luyue Chen; Lei Han; Jianwei Wei; Kailiang Zhang; Zhendong Shi; Ran Duan; Shouwei Li; Xuan Zhou; Peiyu Pu; Jianning Zhang; Chunsheng Kang
Journal:  Sci Rep       Date:  2015-02-26       Impact factor: 4.379

6.  DNA methylation signatures in cord blood of ICSI children.

Authors:  Nady El Hajj; Larissa Haertle; Marcus Dittrich; Sarah Denk; Harald Lehnen; Thomas Hahn; Martin Schorsch; Thomas Haaf
Journal:  Hum Reprod       Date:  2017-08-01       Impact factor: 6.918

7.  Small Non-coding RNA Abundance in Adrenocortical Carcinoma: A Footprint of a Rare Cancer.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Dino J Ravnic
Journal:  J Genomics       Date:  2017-09-08

8.  Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implications.

Authors:  Cai Han; Lin-Yu Sun; Wen-Tao Wang; Yu-Meng Sun; Yue-Qin Chen
Journal:  J Mol Cell Biol       Date:  2019-10-25       Impact factor: 6.216

9.  Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia.

Authors:  Susanna Teppo; Saara Laukkanen; Thomas Liuksiala; Jessica Nordlund; Mikko Oittinen; Kaisa Teittinen; Toni Grönroos; Pascal St-Onge; Daniel Sinnett; Ann-Christine Syvänen; Matti Nykter; Keijo Viiri; Merja Heinäniemi; Olli Lohi
Journal:  Genome Res       Date:  2016-09-12       Impact factor: 9.043

10.  In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL.

Authors:  S Laukkanen; T Grönroos; P Pölönen; H Kuusanmäki; J Mehtonen; J Cloos; G Ossenkoppele; B Gjertsen; B Øystein; C Heckman; M Heinäniemi; M Kontro; O Lohi
Journal:  Blood Cancer J       Date:  2017-09-08       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.